The India cold chain pharmaceutical logistics market size reached USD 0.57 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 0.80 Billion by 2033, exhibiting a growth rate (CAGR) of 3.20% during 2025-2033. The India cold chain pharmaceutical logistics market share is expanding, driven by the rising adoption of biosimilars, gene therapies, and specialty drugs, creating the need for precise temperature control solutions, along with the ongoing execution of government initiatives that promote digital healthcare and telemedicine, encouraging investments in modern cold chain logistics infrastructure.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 0.57 Billion |
Market Forecast in 2033 | USD 0.80 Billion |
Market Growth Rate (2025-2033) | 3.20% |
Increasing pharmaceutical exports
Rising pharmaceutical exports are impelling the India cold chain pharmaceutical logistics market growth. India is one of the largest producers and exporters of generic medicines, vaccines, and biologics, with a high demand from international markets. According to the data published on the official website of the Ministry of Commerce and Industry, the Indian exports of drugs and pharmaceuticals rose by 7.22%, reaching USD 2.39 Billion in September 2023 to USD 2.57 Billion by September 2024. Many of these pharmaceutical items are temperature-sensitive and require strict cold chain management to maintain their efficacy during transit. Export regulations from developed and developing countries mandate compliance with worldwide quality standards, encouraging Indian pharmaceutical companies to invest in advanced cold chain pharmaceutical logistics. The expansion of biosimilars, gene therapies, and specialty drugs further drives the demand for precise temperature control solutions. Logistics providers are responding by developing modern cold storage facilities, refrigerated transportation, and real-time monitoring systems to ensure product safety. Additionally, government initiatives and incentives to boost pharmaceutical exports are attracting investments in cold chain infrastructure.
Rise in home healthcare and online pharmacies
An increase in home healthcare and online pharmacies is offering a favorable India cold chain pharmaceuticals logistics market outlook. In December 2024, Flipkart, the e-commerce firm, was set to introduce a fast medicine delivery service named ‘Flipkart Minutes,’ with the goal of completing orders in just 10 minutes in India. Flipkart Minutes functioned in Bengaluru, Delhi-NCR, and Mumbai, intending to grow into 8-10 key cities, such as Hyderabad, Chennai, Kolkata, and Pune. With more people ordering medicines, vaccines, and other critical drugs online, logistics providers must ensure these temperature-sensitive products reach customers safely and efficiently. Many medicines, including insulin, biologics, and certain antibiotics, require strict temperature control during transit to maintain their effectiveness. Cold chain logistics providers are expanding their fleet of refrigerated vehicles and last-mile delivery solutions for catering to the high demand. Home healthcare services, which involve delivering medical supplies and diagnostic kits directly to patients, also require reliable cold storage and transport solutions. The rise in chronic diseases and an aging population further creates the need for timely and safe medicine deliveries. Additionally, government initiatives promoting digital healthcare and telemedicine are encouraging investments in advanced cold chain logistics infrastructure. Companies are utilizing the Internet of Things (IoT)-based temperature monitoring and real-time tracking systems to enhance supply chain efficiency.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on product and service.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the products. This includes vaccines, biopharmaceuticals, and clinical trial materials.
Service Insights:
A detailed breakup and analysis of the market based on the services have also been provided in the report. This includes warehousing and VAS and transportation.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Vaccines, Biopharmaceuticals, Clinical Trial Materials |
Services Covered | Warehousing and VAS, Transportation |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: